BAM
MLAB icon

Belpointe Asset Management’s Mesa Laboratories MLAB Stock Holding History

Belpointe Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-41
Closed -$7.16K – 2242
2023
Q1 		$7.16K Buy
+41
New +$7.35K ﹤0.01% 2880

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Belpointe Asset Management's MLAB Position: Q2 2023 in Review

Belpointe Asset Management sold out of Mesa Laboratories (MLAB) in Q2 2023, closing a stake of 41 shares — an estimated $7.16K sold.

Belpointe Asset Management first reported a position in MLAB in Q1 2023 and held it in 1 quarter. The position peaked at $7.16K in Q1 2023. 161 funds tracked by Wall St. Rank hold MLAB as of Q2 2023.

  • Belpointe Asset Management reported no remaining Mesa Laboratories position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 41 Mesa Laboratories shares in Q2 2023, an estimated $7.16K.
  • Belpointe Asset Management first reported a position in Mesa Laboratories in Q1 2023 and held it in 1 quarter.
  • Belpointe Asset Management's Mesa Laboratories position peaked at $7.16K in Q1 2023.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.